New England Journal of Medicine Publishes eNRGy Trial Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer ...

With one in every nine Indians at risk of developing cancer and a 12.8 per cent projected increase in annual cases by 2025, these daycare cancer centers will play a crucial role in reducing the burden ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.

The publication reviews the results of 204 patients with 12 tumor types enrolled and treated on the eNRGy study, concluding “Zenocutuzumab demonstrated durable efficacy in patients with advanced NRG1+ ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...

A new study found that the proportion of people being diagnosed with lung cancer who have never smoked is increasing, and air ...

A recent study published in The Lancet Respiratory Medicine revealed an increase in lung cancer cases among non-smokers, ...

Amy Schumer revealed she has Cushing syndrome amid concerns about her "moon face." Here's what to know about the rare ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

Trusted resource of information on Cancer that includes articles, news, videos, animations, quizzes, calculators and drugs.

Experts have analyzed data to discover why non-smokers are developing lung cancer, and it is down to air pollution in our ...